Skip to main content

Table 5 Morbidity and mortality in dependency of diagnosis

From: Retrospective analyses of trends in pancreatic surgery: indications, operative techniques, and postoperative outcome of 1,120 pancreatic resections

 

PDAC

Periampullary carcinoma

Chronic pancreatitis

pNET

IPMN

Other

P value

( n= 380)

( n= 160)

( n= 360)

( n= 48)

( n= 42)

( n= 125)

Mortality

16 (4.2%)

4 (2.5%)

5 (1.4%)

0 (0.0%)

2 (4.8%)

0 (0.0%)

<0.05

Overall morbidity

194 (51.1%)

101 (63.1%)

161 (44.1%)

22 (45.8%)

25 (59.5%)

75 (60.0%)

<0.001

Operation-related morbidity

131 (34.5%)

76 (47.5%)

121 (33.2%)

23 (47.9%)

23 (54.8%)

70 (56.0%)

<0.001

Reoperation

40 (10.5%)

21 (13.1%)

35 (9.6%)

6 (12.5%)

11 (26.2%)

14 (11.2%)

<0.05

Pancreatic fistula grades A to C

70 (18.4%)

62 (38.8%)

68 (18.6%)

23 (47.9%)

15 (35.7%)

58 (46.4%)

<0.001

  1. Number (percentage). PDAC, pancreatic ductal adenocarcinoma; pNET, primitive neuroectodermal tumor; IPMN, intraductal papillary mucinous neoplasm.